stockrow
Friday 6 November 2026
Export DH’s income statement to Excel — free account
Definitive Healthcare Corp.
DH Healthcare Health Information Services
Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024.
- Revenue
- −8.99%
- EPS
- +71.4%
- Free cash flow
- −32.6%
- Total debt
- −5.03%
Quarter to September 2026, against a year earlier
1.16
0.03
+2.65%
Follow DH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.27 | 0.54 | 0.38 | 0.43 | |
P/FCF ratio |
8.26 | 4.76 | 3.07 | 4.02 | |
P/Operating CF |
112.53 | 11.13 | 7.67 | 8.51 | |
P/B ratio |
0.81 | 0.68 | 0.47 | 0.52 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.20 | 0.48 | 0.28 | 0.29 | |
EV/EBITDA |
6.55 | 2.38 | 1.46 | 1.48 | |
EV/Operating CF |
5.39 | 2.89 | 1.57 | 1.77 | |
EV/FCF |
7.83 | 4.19 | 2.27 | 2.72 | |
Quick Ratio |
1.49 | 1.55 | 1.66 | 1.77 | |
Current Ratio |
1.64 | 1.75 | 1.86 | 1.96 | |
Net Debt/EBITDA |
(1.48) | (1.17) | (2.10) | 0.00 | |
Debt/Assets |
22.41% | 31.62% | 32.33% | 32.44% | |
Debt/Equity |
0.43 | 0.85 | 0.86 | 0.84 | |
Asset Turnover |
0.26 | 0.36 | 0.37 | 0.37 | |
Operating CF/Net income |
(0.29) | (0.08) | (2.11) | (2.93) | |
Capex/Depreciation |
(0.12) | (0.01) | (0.17) | 0.00 | |
Interest Coverage |
(9.29) | (76.57) | (2.57) | (1.87) | |
Research and Development Expense of Revenue |
16.18% | 11.62% | 12.24% | 12.20% | |
Selling, General and Administrative Expense of Revenue |
56.00% | 56.61% | 54.29% | 57.66% | |
Intangible Assets out of Total Assets |
0.60 | 0.46 | 0.45 | 0.00 | |
Share Based Compensation of Revenue |
13.26% | 9.33% | 9.52% | 10.11% | |
Graham Net Nets |
(0.32) | (0.61) | (0.78) | (0.58) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(43.55%) | (131.71%) | (192.77%) | (164.84%) | |
Free Cash Flow Yield |
12.11% | 21.02% | 32.52% | 24.90% | |
Revenue per Share |
0.58 | 0.53 | 0.52 | 0.51 | |
Operating CF per Share |
0.03 | 0.11 | 0.11 | 0.11 | |
Capex per Share |
(0.04) | (0.03) | (0.03) | (0.02) | |
Free Cash Flow per Share |
(0.02) | 0.08 | 0.08 | 0.08 | |
Cash per Share |
1.70 | 1.70 | 1.74 | 1.78 | |
Shareholders Equity per Share |
3.55 | 1.82 | 1.78 | 1.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.55 | 1.82 | 1.78 | 1.77 | |
Free Cash Flow |
(1.72) | 8.36 | 8.51 | 9.04 | |
Working Capital |
100.82 | 105.35 | 111.03 | 119.57 | |
Capital Expenditures |
(4.44) | (3.20) | (2.94) | (2.39) | |
Net Current Asset Value |
(98.89) | (78.28) | (68.87) | (56.46) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.06 | 0.05 | 0.04 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
52.61 | 40.93 | 34.24 | 31.94 | |
Average Payables |
7.18 | 7.12 | 6.21 | 7.20 | |
Average Assets |
912.44 | 661.70 | 633.49 | 622.09 | |
Average Common Equity |
493.09 | 313.30 | 299.55 | 289.07 |
Columns are period end dates · fundamentals updated 5 Nov 2026